• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sulfasalazine. Adverse effects and desensitization.

作者信息

Taffet S L, Das K M

出版信息

Dig Dis Sci. 1983 Sep;28(9):833-42. doi: 10.1007/BF01296907.

DOI:10.1007/BF01296907
PMID:6136396
Abstract
摘要

相似文献

1
Sulfasalazine. Adverse effects and desensitization.柳氮磺胺吡啶。不良反应与脱敏疗法。
Dig Dis Sci. 1983 Sep;28(9):833-42. doi: 10.1007/BF01296907.
2
Sulfasalazine in the rheumatic disease.柳氮磺胺吡啶在风湿性疾病中的应用。
Semin Arthritis Rheum. 1988 May;17(4):246-59. doi: 10.1016/0049-0172(88)90010-8.
3
Sulphasalazine: a 'new' antirheumatic drug.
Br J Rheumatol. 1984 Feb;23(1):26-34. doi: 10.1093/rheumatology/23.1.26.
4
Sulfasalazine hypersensitivity with hepatotoxicity, thrombocytopenia, and erythroid hypoplasia.柳氮磺胺吡啶超敏反应伴肝毒性、血小板减少和红细胞生成低下。
J Pediatr Gastroenterol Nutr. 1989 Aug;9(2):261-3. doi: 10.1097/00005176-198908000-00021.
5
Untoward effects of antimicrobial agents on major organ systems.抗菌药物对主要器官系统的不良影响。
Med Clin North Am. 1974 May;58(3):465-78. doi: 10.1016/s0025-7125(16)32136-8.
6
Sulfasalazine and pulmonary infiltrates.
Am J Gastroenterol. 1984 Jan;79(1):77.
7
Fatal massive hepatic necrosis: a probable hypersensitivity reaction to sulfasalazine.
Am J Gastroenterol. 1986 Mar;81(3):205-8.
8
Common adverse effects of antibacterial agents on major organ systems.抗菌药物对主要器官系统的常见不良反应。
Surg Clin North Am. 1980 Feb;60(1):65-81. doi: 10.1016/s0039-6109(16)42034-7.
9
Hypersensitivity reaction to sulfasalazine: skin rash, fever, hepatitis and activated lymphocytes.
Clin Exp Rheumatol. 1992 Jul-Aug;10(4):427.
10
Sulfasalazine hepatotoxicity.
Am J Dis Child. 1981 Nov;135(11):1070-2. doi: 10.1001/archpedi.1981.02130350070025.

引用本文的文献

1
Safety assessment of sulfasalazine: a pharmacovigilance study based on FAERS database.柳氮磺胺吡啶的安全性评估：一项基于FAERS数据库的药物警戒研究。
Front Pharmacol. 2024 Sep 12;15:1452300. doi: 10.3389/fphar.2024.1452300. eCollection 2024.
2
Integrating the gut microbiome and pharmacology.整合肠道微生物组和药理学。
Sci Transl Med. 2024 Jan 31;16(732):eadg8357. doi: 10.1126/scitranslmed.adg8357.
3
The aminosalicylate - folate connection.氨基水杨酸盐-叶酸的关联。

本文引用的文献

1
The treatment of 124 cases of ulcerative colitis with salazopyrine and attempts of desensibilization in cases of hypersensitiveness to sulfa.用柳氮磺胺吡啶治疗124例溃疡性结肠炎，并对磺胺过敏病例进行脱敏尝试。
Acta Med Scand. 1948;131(Suppl 206):465-72. doi: 10.1111/j.0954-6820.1948.tb12083.x.
2
A fatal case of azulfidine-induced agranulocytosis.柳氮磺胺吡啶诱发粒细胞缺乏症致死病例。
Gastroenterology. 1959 Dec;37:787-9.
3
LUPUS ERYTHEMATOSUS CELL PHENOMENON IN PATIENTS WITH CHRONIC ULCERATIVE COLITIS.慢性溃疡性结肠炎患者的红斑狼疮细胞现象
Drug Metab Rev. 2024 Feb;56(1):80-96. doi: 10.1080/03602532.2024.2303507. Epub 2024 Jan 17.
4
A Case Report of Intratesticular Hematoma in a Patient with Reiter's Syndrome.赖特综合征患者睾丸内血肿1例报告
Diagnostics (Basel). 2023 Jun 7;13(12):1993. doi: 10.3390/diagnostics13121993.
5
Contribution of Lipid Oxidation and Ferroptosis to Radiotherapy Efficacy.脂质氧化和铁死亡对放疗疗效的贡献。
Int J Mol Sci. 2021 Nov 22;22(22):12603. doi: 10.3390/ijms222212603.
6
Effect of inflammatory bowel disease treatments on patients with diabetes mellitus.炎症性肠病治疗对糖尿病患者的影响。
World J Diabetes. 2021 Aug 15;12(8):1248-1254. doi: 10.4239/wjd.v12.i8.1248.
7
Drug-Drug Compatibility Evaluation of Sulfasalazine and Folic Acid for Fixed-Dose Combination Development Using Various Analytical Tools.使用各种分析工具对柳氮磺胺吡啶和叶酸进行固定剂量复方开发的药物-药物相容性评估。
Pharmaceutics. 2021 Mar 17;13(3):400. doi: 10.3390/pharmaceutics13030400.
8
The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis.NAT2 乙酰化状态与柳氮磺吡啶不良反应的关系：系统评价和荟萃分析。
Sci Rep. 2020 Feb 27;10(1):3658. doi: 10.1038/s41598-020-60467-8.
9
Effect of a Nutrition Support Formula in Adults With Inflammatory Bowel Disease: A Pilot Study.营养支持配方对成人炎症性肠病的影响：一项试点研究。
Glob Adv Health Med. 2019 Jul 29;8:2164956119867251. doi: 10.1177/2164956119867251. eCollection 2019.
10
Insights into the treatment of inflammatory bowel disease in pregnancy.妊娠期炎症性肠病的治疗见解。
Therap Adv Gastroenterol. 2019 May 27;12:1756284819852231. doi: 10.1177/1756284819852231. eCollection 2019.
Gut. 1965 Feb;6(1):39-47. doi: 10.1136/gut.6.1.39.
4
CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.柳氮磺胺吡啶治疗溃疡性结肠炎的对照试验
Gut. 1964 Oct;5(5):437-42. doi: 10.1136/gut.5.5.437.
5
THE OCCURRENCE OF HEINZ BODIES DURING AZULFIDINE TREATMENT OF ULCERATIVE COLITIS.柳氮磺胺吡啶治疗溃疡性结肠炎期间海因茨小体的出现情况。
Gastroenterologia. 1963;100:33-41. doi: 10.1159/000202343.
6
AGRANULOCYTOSIS DUE TO ADMINISTRATION OF SALICYLAZOSULFAPYRADINE (AZULFIDINE).
Med Bull US Army Eur. 1963 Sep;20:270-1.
7
Agranulocytosis associated with sulphasalazine ('Salazopyrin') therapy.
Lancet. 1963 Jun 29;1(7296):1395-7. doi: 10.1016/s0140-6736(63)92048-8.
8
[3 cases of medicamentous agranulocytosis: Largactil, Cibalgin, Salazopyrine].
Ugeskr Laeger. 1962 Feb 2;124:144-6.
9
Sulphasalazine and salicylazosulphadimidine in ulcerative colitis.柳氮磺胺吡啶和水杨酸偶氮磺胺嘧啶治疗溃疡性结肠炎
Lancet. 1962 May 26;1(7239):1094-6. doi: 10.1016/s0140-6736(62)92080-9.
10
Heinz-body anaemia due to salicylazosulphapyridine.柳氮磺胺吡啶所致的海因茨小体贫血
Lancet. 1958 May 17;1(7029):1039-42. doi: 10.1016/s0140-6736(58)92005-1.